The drugs that have cancer on the run

Checkpoint inhibitors offer another approach for tackling advanced melanoma

Attempts to improve the survival of patients with advanced or metastatic melanoma have, until recently, proven futile.

A CTLA-4 protein. CTLA4-blocking antibodies are used in cancer therapy (immune checkpoint blockade therapy). Photo: Alamy
A CTLA-4 protein. CTLA4-blocking antibodies are used in cancer therapy (immune checkpoint blockade therapy). Photo: Alamy

However, emerging targeted therapies and immune checkpoint inhibitors induce high

Latest